Listed

Turn Therapeutics Inc.

TTRXNasdaqCIK 2023016HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$1.6m, Q2 FY2026
Net income−$5.8m, Q2 FY2026
Line itemUnitperiod not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k153Research and development, period not labelled, three months to 2024-09-30$153.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure9.8Research and development, period not labelled, three months to 2024-12-31$9.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure9.3Research and development, period not labelled, three months to 2025-03-31$9.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure62.7Research and development, period not labelled, three months to 2025-06-30$62.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure159Research and development, Q3 FY2025, three months to 2025-09-30$158.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure34.9Research and development, Q4 FY2025, three months to 2025-12-31$34.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure109Research and development, Q1 FY2026, three months to 2026-03-31$109.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure475Research and development, Q2 FY2026, three months to 2026-06-30$475.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Operating income$k(673)Operating income, period not labelled, three months to 2024-09-30−$673.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure(329)Operating income, period not labelled, three months to 2024-12-31−$329.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(385)Operating income, period not labelled, three months to 2025-03-31−$385.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(1,367)Operating income, period not labelled, three months to 2025-06-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure(1,914)Operating income, Q3 FY2025, three months to 2025-09-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure(2,194)Operating income, Q4 FY2025, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(1,246)Operating income, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(1,628)Operating income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Net income$k(666)Net income, period not labelled, three months to 2024-09-30−$666.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure(323)Net income, period not labelled, three months to 2024-12-31−$323.1k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(329)Net income, period not labelled, three months to 2025-03-31−$328.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(1,240)Net income, period not labelled, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure(1,904)Net income, Q3 FY2025, three months to 2025-09-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure279Net income, Q4 FY2025, three months to 2025-12-31$279.1k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(971)Net income, Q1 FY2026, three months to 2026-03-31−$971.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(5,850)Net income, Q2 FY2026, three months to 2026-06-30−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Diluted EPS$ per share(0.03)Diluted EPS, period not labelled, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figurenot reported(0.01)Diluted EPS, period not labelled, three months to 2025-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(0.05)Diluted EPS, period not labelled, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Basic EPS$ per share(0.03)Basic EPS, period not labelled, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figurenot reported(0.01)Basic EPS, period not labelled, three months to 2025-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(0.05)Basic EPS, period not labelled, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure

Balance sheet

Cash and equivalents$9.9m, Q2 FY2026
Long-term debt$6.1m, Q2 FY2026
Shareholders' equity$686.9k, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported0.5Cash and equivalents, period not labelled, at 2024-09-30$498.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure0.5Cash and equivalents, period not labelled, at 2024-12-31$498.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figurenot reportednot reported0.5Cash and equivalents, Q3 FY2025, at 2025-09-30$513.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure4.0Cash and equivalents, FY2025, at 2025-12-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure11.0Cash and equivalents, Q1 FY2026, at 2026-03-31$11.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure9.9Cash and equivalents, Q2 FY2026, at 2026-06-30$9.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Current assets$mnot reportednot reported1.1Current assets, period not labelled, at 2024-12-31$1.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figurenot reportednot reported3.3Current assets, Q3 FY2025, at 2025-09-30$3.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure5.2Current assets, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure11.5Current assets, Q1 FY2026, at 2026-03-31$11.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure10.4Current assets, Q2 FY2026, at 2026-06-30$10.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Total assets$mnot reportednot reported2.0Total assets, period not labelled, at 2024-12-31$2.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figurenot reportednot reported4.3Total assets, Q3 FY2025, at 2025-09-30$4.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure12.2Total assets, FY2025, at 2025-12-31$12.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure18.6Total assets, Q1 FY2026, at 2026-03-31$18.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure17.0Total assets, Q2 FY2026, at 2026-06-30$17.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Current liabilities$mnot reportednot reported0.7Current liabilities, period not labelled, at 2024-12-31$707.9k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figurenot reportednot reported2.3Current liabilities, Q3 FY2025, at 2025-09-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure6.0Current liabilities, FY2025, at 2025-12-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure5.1Current liabilities, Q1 FY2026, at 2026-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure8.8Current liabilities, Q2 FY2026, at 2026-06-30$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Total liabilities$mnot reportednot reported2.2Total liabilities, period not labelled, at 2024-12-31$2.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figurenot reportednot reported3.8Total liabilities, Q3 FY2025, at 2025-09-30$3.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure7.5Total liabilities, FY2025, at 2025-12-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure12.5Total liabilities, Q1 FY2026, at 2026-03-31$12.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure16.3Total liabilities, Q2 FY2026, at 2026-06-30$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported5.9Long-term debt, Q1 FY2026, at 2026-03-31$5.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure6.1Long-term debt, Q2 FY2026, at 2026-06-30$6.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure
Shareholders' equity$m0.1Shareholders' equity, period not labelled, at 2023-12-31$85.8k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001213900-26-037505.Report this figure(0.4)Shareholders' equity, period not labelled, at 2024-09-30−$414.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure(0.2)Shareholders' equity, period not labelled, at 2024-12-31−$177.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure0.8Shareholders' equity, period not labelled, at 2025-03-31$818.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure1.8Shareholders' equity, period not labelled, at 2025-06-30$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure0.5Shareholders' equity, Q3 FY2025, at 2025-09-30$504.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure4.7Shareholders' equity, FY2025, at 2025-12-31$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure6.1Shareholders' equity, Q1 FY2026, at 2026-03-31$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure0.7Shareholders' equity, Q2 FY2026, at 2026-06-30$686.9k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure

Cash flow

Operating cash flow−$923.4k, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(431)Operating cash flow, period not labelled, three months to 2024-12-31−$430.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(298)Operating cash flow, period not labelled, three months to 2025-03-31−$298.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(500)Operating cash flow, period not labelled, three months to 2025-06-30−$500.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088427. Derived: 6-month figure less the 3-month figure.Report this figure(589)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$588.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109586. Derived: 9-month figure less the 6-month figure.Report this figure(1,176)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001213900-26-037505. Derived: 12-month figure less the 9-month figure.Report this figure(1,633)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure(923)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$923.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088427. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)29.79m, Q2 FY2026
Line itemUnitperiod not labelled2024-09-30period not labelled2025-03-31period not labelled2025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares26.6Diluted shares (weighted), period not labelled, three months to 2024-09-3026,645,835 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure27.0Diluted shares (weighted), period not labelled, three months to 2025-03-3126,956,217 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure27.5Diluted shares (weighted), period not labelled, three months to 2025-06-3027,494,483 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure28.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3027,975,207 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001213900-25-109586.Report this figure29.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3129,476,002 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001213900-26-054490.Report this figure29.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3029,788,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure

Shares outstanding: 29.79mShares outstanding, period not labelled, at 2026-08-1229,788,040 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088427.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.